Skip to main content
SpringerLink
Log in

Hereditäre Myopathien

  • Chapter
Klinische Neurologie

  • 13k Accesses

Zusammenfassung

Muskeldystrophien bilden eine klinisch und genetisch heterogene Gruppe primär degenerativer, progressiver Muskelerkrankungen. Das Manifestationsalter reicht von der frühen Kindheit bis in das späte Erwachsenenalter. Bei vielen Formen ist inzwischen der zugrunde liegende Genort und auch das defekte Genprodukt bekannt. Dies hat zu einer neuen Klassifikation der Muskeldystrophien geführt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zitierte Literatur

  • Deschauer M, Wieser T, Zierz S (2005) Muscle carnitine palmitoyltransferase II deficiency. Arch Neurol 62: 37–41

    Article  PubMed  Google Scholar 

  • DiMauro S, Tsujino S (1994) Nonlysosomal glycogenoses. In: Engel AG, Franzini-Armstrong C (eds) Myology, vol 2. McGraw-Hill, New York, pp 1554–1576

    Google Scholar 

  • Hirano M, Ricci E, Koenigsberger MR et al. (1992) MELAS: An original case and clinical criteria for diagnosis. Neuromuscul Disord 2: 125–135

    Article  PubMed  CAS  Google Scholar 

  • Ricker K, Koch MC, Lehmann-Horn F, Pongratz D Otto M, Heine R, Moxley RT (1994) Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44: 1448–1452

    PubMed  CAS  Google Scholar 

  • Zierz S (1994) Carnitine palmitoyltransferase deficiency. In: Engel AG, Franzini-Armstrong C (eds) Myology, vol 2. McGraw-Hill, New York, pp 1577–1586

    Google Scholar 

  • Zierz S, Engel AG (1985) Regulatory properties of a mutant carnitine palmitoyl transferase in human skeletal muscle. Eur J Biochem 149: 207–214

    Article  PubMed  CAS  Google Scholar 

  • Zierz S, Wersebe O von, Gerbitz KD, Jerusalem F (1990) Ophthalmoplegia plus: Klinische Variabilität, biochemische Defekte der mitochondrialen Atmungskette und Deletionen des mitochondrialen Genoms. Nervenarzt 61: 332–339

    PubMed  CAS  Google Scholar 

Weiterführende Literatur

  • Brevister B, Groenen P, Wieringa B (1998) Myotonic dystrophy: Clinical and molecular aspects. In: Emery AEH (ed) Neuromuscular disorders: Clinical and molecular genetics. Wiley, Chichester, pp 323–364

    Google Scholar 

  • Brook JD, McCurrach ME, Harley HG et al. (1992) Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3‘ end of a transcript encoding a protein kinase family member. Cell 68: 799–808

    Article  PubMed  CAS  Google Scholar 

  • Bruno C, DiMauro S (2008) Lipid storage myopathies. Curr Opin Neurol 21: 601–606

    Article  PubMed  CAS  Google Scholar 

  • Chinnery PF, Bindoff LA (2003) 116th ENMC International Workshop: The treatment of mitochondrial disorders, March 14–16, 2003, Naarden, The Netherlands. Neuromuscul Disord 13: 757–764

    Article  PubMed  CAS  Google Scholar 

  • Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12: 329–343

    Article  PubMed  CAS  Google Scholar 

  • Davies KE (1997) Challenges in Duchenne muscular dystrophy. Neuromuscul Disord 7: 482–486

    Article  PubMed  CAS  Google Scholar 

  • Day JW, Ranum LP (2005) RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 15: 5–16

    Article  PubMed  Google Scholar 

  • Deschauer M, Zierz S (2003) Defekte der intergenomischen Kommunikation: Mutationen der Kern-DNA und multiple Deletionen der mitochondrialen DNA bei chronisch progressiver externer Ophthalmoplegie. Akt Neurol 30: 103–106

    Article  Google Scholar 

  • Deschauer M, Zierz S (2007) Chronic progressive external ophthalmoplegia – a common manifestation of mitochondrial disorders. In: Lorenz B, Borruat FX (eds) Essentials in ophthalmology: Pediatric ophthalmology, neuroophthalmology, genetics. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Deschauer M, Müller T, Wieser T, Schulte-Mattler W, Kornhuber M, Zierz S (2001) Hearing impairment is common in various phenotypes of the mitochondrial DNA A3243G mutation. Arch Neurol 58: 1885–1888

    Article  PubMed  CAS  Google Scholar 

  • Deschauer M, Swalwell H, Strauss M, Zierz S, Taylor RW (2006) Novel mitochondrial tRNAPhe gene mutation associated with late-onset neuromuscular disease. Arch Neurol 63: 902–905

    Article  PubMed  Google Scholar 

  • Deschauer M, Tennant S, Rokicka A et al. (2007) MELAS associated with mutations in the POLG1 gene. Neurology 68: 1741–1742

    Article  PubMed  CAS  Google Scholar 

  • Deschauer M, Morgenroth A, Joshi PR et al. (2007) Analysis of spectrum and frequencies of mutations in McArdle disease: Identification of 13 novel mutations. J Neurol 254: 797–802

    Article  PubMed  CAS  Google Scholar 

  • DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348: 2656–2668

    Article  PubMed  CAS  Google Scholar 

  • Eger K, Schulte-Mattler WJ, Zierz S (1997) Proximale myotone Myopathie (PROMM). Nervenarzt 68: 839–844

    Article  PubMed  CAS  Google Scholar 

  • Emery AEH (ed) (1997) Diagnostic criteria for neuromuscular disorders, 2nd edn. Royal Society of Medicine, London

    Google Scholar 

  • Emery AEH (ed) (1998) Neuromuscular disorders: Clinical and molecular genetics. Wiley, Chichester

    Google Scholar 

  • Engel A, Franzini-Armstrong C (eds) (2004) Myology, 3rd edn, vol 1 and 2. McGraw-Hill, New York

    Google Scholar 

  • Gaul C, Deschauer M, Tempelmann C et al. (2006) Cardiac involvement in limb-girdle muscular dystrophy 2I (LGMD2I) – conventional cardiac diagnostic and cardiovascular magnetic resonance (CMR). J Neurol 253: 1317–1322

    Article  PubMed  CAS  Google Scholar 

  • Hanisch F, Müller T, Muser A, Deschauer M, Zierz S (2006) Lactate increase and oxygen desaturation in mitochondrial disorders – Evaluation of two diagnostic screening protocols. J Neurol 253: 417–423

    Article  PubMed  CAS  Google Scholar 

  • Harper PS, Baziel van Engelen B, Eymard B, Wilcox D (2004) Myotonic dystrophy: present management, future therapy. Oxford University Press, Oxford

    Google Scholar 

  • Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 118: 339–357

    Article  PubMed  Google Scholar 

  • Joshi PR, Gläser D, Schmidt S et al. (2008) Molecular genetic characterization of German patients with late-onset glycogen storage disease type II. J Inherit Metab Dis. DOI 10.1007/s10545-008-0820-2

    Google Scholar 

  • Kakulas BA (1996) The differential diagnosis of the human dystrophinopathies and related disorders. Curr Opin Neurol 9: 380–388

    Article  PubMed  CAS  Google Scholar 

  • Klopstock T, Gasser T (1999) Genetische Beratung und pränatale Diagnostik bei Mitochondrialen Erkrankungen. Nervenarzt 70: 504–508

    Article  PubMed  CAS  Google Scholar 

  • Lim LE, Campbell KP (1998) The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol 11: 443–452

    Article  PubMed  CAS  Google Scholar 

  • Liu J, Aoki M, Illa I et al. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20: 31–36

    Article  PubMed  CAS  Google Scholar 

  • Lukacs Z, Nieves-Cobos P, Mengel E et al. (2010) Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening. J Inherit Metab Dis 33: 43–50

    Article  PubMed  CAS  Google Scholar 

  • Lucia A, Nogales-Gadea G, Perez M et al. (2008) McArdle disease: What do neuroligsts need to know. Nature Clin Pract 10: 568–577

    Article  Google Scholar 

  • Machuca-Tzili L, Brook D, Hilton-Jones D (2005) Clinical and molecular aspects of the myotonic dystrophies: A review. Muscle Nerve 32: 1–18

    Article  PubMed  CAS  Google Scholar 

  • Manilal S, Recan D, Sewry CA et al. (1998) Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression. Hum Mol Genet 7: 855–864

    Article  PubMed  CAS  Google Scholar 

  • Mastaglia FL, Lamont PJ, Laing NG (2005) Distal myopathies. Curr Opin Neurol 18: 504–510

    Article  PubMed  CAS  Google Scholar 

  • Matthews E, Fialho D, Tan SV et al. (2010) The non-dystrophic myotonias: Molecular pathogenesis, diagnosis and treatment. Brain 133: 9–22

    Article  PubMed  CAS  Google Scholar 

  • Meyer-Kleine C, Steinmeyer K, Ricker K, Jentsch T, Koch MC (1995) Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCNI) leading to myotonia. Am J Hum Genet 57: 1325–1334

    PubMed  CAS  Google Scholar 

  • Müller T, Deschauer M, Kolbe-Fehr F, Zierz S (2006) Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy. J Neurol 253: 892–895

    Article  PubMed  Google Scholar 

  • Ricker K, Koch MC, Lehmann-Horn F et al. (1995) Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 52: 25–31

    PubMed  CAS  Google Scholar 

  • Riordan-Eva P, Wood NW (1996) Mitochondrial disorders in neuroophthalmology. Curr Opin Neurol 9: 1–4

    Article  PubMed  CAS  Google Scholar 

  • Rüdel R, Lehmann-Horn F (1998) Muscle ion channel diseases: Non-dystrophic myotonias, periodic paralyses, and malignant hyperthermia. In: Emery AEH (ed) Neuromuscular disorders: Clinical and molecular genetics. Wiley, Chichester, pp 365–420

    Google Scholar 

  • Strothotte S, Strigl-Pill N, Grunert B et al. (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2. 12-month results of an observational clinical trial. J Neurol 257: 91–97

    Article  PubMed  CAS  Google Scholar 

  • Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM (2004) The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 14: 237–245

    Article  PubMed  Google Scholar 

  • The FSH-DY Group (1997) A prospective, quantitative study of the natural history of facioscapulohumeral muscular dys trophy (FSHD): Implications for therapeutic trials. Neurology 48: 38–46

    Google Scholar 

  • Taivassalo T, Gardner JL, Taylor RW et al. (2006) Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain129: 3391–3401

    Article  PubMed  Google Scholar 

  • Van der Ploeg AT, Clemens PR, Corza D et al. (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. New Engl J Med 362: 1396–1406

    Article  PubMed  Google Scholar 

  • Voit T, Krogmann O, Lenard HG et al. (1988) Emery-Dreifuss muscular dystrophy: Disease spectrum and differential diagnosis. Neuropediatrics 19: 62–71

    Article  PubMed  CAS  Google Scholar 

  • Vorgerd M, Deschauer M (2011) Management and treatment of hereditary metabolic myopathies. In: Bertorini TE (ed), Neuromuscular disorders: Treatment and management. Saunders, Philadelphia

    Google Scholar 

  • Wallgren-Petterson C (1998) Genetics of the Nemaline myopathies and the myotubular myopathies. Neuromuscul Disord 8: 401–404

    Article  Google Scholar 

  • Wewer UM, Engvall E (1996) Merosin/Laminin-2 and muscular dystrophy. Neuromuscul Disord 6: 409–418

    Article  PubMed  CAS  Google Scholar 

  • Wijmenga C, Frants RR, Brouwer OF et al. (1990) Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336: 651–653

    Article  PubMed  CAS  Google Scholar 

  • Winchester B, Bali D, Bodamer AO et al. (2008) Methods for a prompt and reliable laboratory diagnosis of Pompe disease: Report from an international consensus meeting. Mol Genet Metab 93: 275–281

    Article  PubMed  CAS  Google Scholar 

  • Zierz S, Jerusalem F (1989) Mitochondriale Myopathien und Enzephalomyopathien. Nervenarzt 60: 394–400

    PubMed  CAS  Google Scholar 

  • Zierz S, Jerusalem F (2003) Muskelerkrankungen, 3. Aufl. Thieme, Stuttgart

    Google Scholar 

  • Zierz S, Meeßen S, Jerusalem F (1989) Laktat- und Pyruvatblutspiegel in der Diagnostik mitochondrialer Myopathien. Nervenarzt 60: 545–548

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Neurologie, Universitätsklinikum Halle (Saale), Ernst-Grube-Str. 40, 06097, Halle (Saale)

    Prof. Dr. M. Deschauer & Prof. Dr. S. Zierz

Authors
  1. Prof. Dr. M. Deschauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. S. Zierz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. J. Schulte-Mattler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Neurologie, Alfried Krupp Krankenhaus Rüttenscheid, Alfried-Krupp-Straße 21, 45117, Essen

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Deschauer, M., Zierz, S., Schulte-Mattler, W. (2011). Hereditäre Myopathien. In: Berlit, P. (eds) Klinische Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16920-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16920-5_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16919-9

  • Online ISBN: 978-3-642-16920-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation